Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Atrioventricular Node Reentry Supraventricular Tachycardia Treatment & Management

  • Author: Glenn T Wetzel, MD, PhD; Chief Editor: Stuart Berger, MD  more...
 
Updated: May 30, 2014
 

Medical Care

Patients with known supraventricular tachycardia (SVT) who are presenting with recurrence and receiving effective therapy usually do not require admission. New patients are frequently admitted for a period of observation and to provide teaching and reassurance to the parent or child. Often, certain antiarrhythmic medications are initiated in the hospital while the patient is monitored for adverse effects (eg, proarrhythmia).

Emergency treatment of patients with hemodynamic instability such as atrioventricular node reentrant tachycardia (AVNRT) is directed at converting the rhythm to sinus through a brief episode of atrioventricular (AV) block.

Perform synchronized electrical cardioversion if patients have a deteriorating condition or if there is no response to the initial attempts of conversion (see below).

As in any other mechanism of supraventricular tachycardia (SVT), the use of vagal maneuvers can be very helpful in the acute setting. In the infant, apply a plastic bag containing ice cubes and water to the face for 25-30 seconds to induce the diving reflex, a vagal stimulus. In older children, other vagal maneuvers can be attempted, such as breathholding or Valsalva maneuver. If this is not successful, the next step is to administer medication. The drug of choice is adenosine, administered from an intravenous site as close as possible to the heart. Importantly, data have indicated low efficacy of recommended doses of adenosine, therefore suggesting the need to redefine current guidelines. Use of esmolol, a short-acting beta-blocker, also has been successful.

Esophageal overdrive atrial pacing is also quite safe and effective in converting to sinus rhythm.

Recording of a long 3- or 12-lead rhythm strip during attempts to terminate the tachycardia may be invaluable in subsequent efforts to define the mechanism of SVT and should be routinely performed.

Transfer

Ideally, as with most tachycardias in children, transfer should take place after successful conversion has been achieved.

Diet

Patients with AVNRT should avoid caffeine-containing items so that SVT is not provoked by caffeine-induced premature beats.

Next

Surgical Care

Knowledge of the anatomy of the Koch triangle (ie, where the AV node is located) is needed to understand how atrioventricular node reentry (AVNR) ablation is performed.[19] The Koch triangle is defined by the ostium of the coronary sinus posteriorly. The apex of the triangle is defined anteriorly by the His bundle. The tendon of Todaro and the tricuspid valve annulus comprise the sides of the triangle. In the electrophysiology laboratory, landmarks of the Koch triangle are identified by one catheter recording the His deflection and by a second catheter placed in the ostium of the coronary sinus. The Koch triangle is located between these 2 catheters.

The fast pathway is anteriorly located, along the tendon of Todaro. The slow pathway is generally located posterior-inferiorly, along the tricuspid annulus, near the ostium of the coronary sinus. However, less common variations have been described.[4, 20]

The electrophysiologic signal is equally important to the anatomic location for determination of appropriate ablation targets.

Ablation of AVNR is accomplished by delivering either radiofrequency or cryothermal energy over the slow pathway. Because its location is more posterior and, thus, distant from the AV node, incidence of complete heart block with the use of radiofrequency energy is low (1.2%).[21] The overall success rate of radiofrequency ablation on AVNRT has been more than 98% over the past several years.

Cryothermal energy has allowed catheter mapping of specific ablation targets. This is especially advantageous in children with AVNRT because it allows greater reversibility of conduction block, decreasing the risk of complete AV block. The cryolesion becomes irreversible at temperatures below -70ºC. The use of cryothermal energy to map and ablate arrhythmia substrates has been shown to be safer than radiofrequency energy; however, this safety comes at the expense of acutely lower success rates and higher recurrence rates at midterm follow-up.[22]

In a survey of physicians who were largely invasive pediatric electrophysiologists (94%) who practice at mid- to high-volume centers (>50 ablation procedures/year), 41% of responders use cryoablation as first-line therapy for atrioventricular nodal reentrant tachycardia.[23]

Success rates of 83% were achieved for pediatric AVNRT cryoablation in a multicenter study. No complications were reported, and, subsequently, the success rate for radiofrequency ablation in the 4 AVNRT cryoablation failures was 100% with the combined approach.[24]

In one single center study, acute success was obtained in 95% of RF (42 patients) and 97% of cryo cases (38 patients). There was one confirmed recurrence of tachycardia in each group, with a 2% recurrence rate.[25]

In another series, 14 pediatric patients with AVNRT had cryoablation success rates of 92.8%, with no complications and a recurrence rate of 30% for AVNRT in 22 months of follow-up.[26]

Another study demonstrated that the fast pathway effective refractory period (ERP) prolongs during AV node modification by cryotherapy, and this can be used as a marker of success. This study indicates that prolongation of more than 20 ms in the fast pathway ERP during cryotherapy application is 70% sensitive and 72% specific for predicting successful slow pathway modification. Subsequent to the procedure, the fast pathway ERP shortens to below baseline levels.[27, 28]

One study of pediatric patients showed a trend toward improved initial success rates (98% vs 93%) and lower early recurrence rates (9% vs 18%) using a 6-mm tip cryoablation catheter as compared with a 4-mm tip catheter.[29]

One study in adult patients emphasized the importance of eliminating AH jumps with retrograde atrial (echo) beats in reducing the recurrence rate.[30] The applicability of this finding to the pediatric population is unclear as the typical findings of dual AV nodal physiology described in adult patients are less common in pediatric patients.[18] Pediatric patients also exhibit an increased prevalence of inducible atypical arrhythmias.[31]

With the use of radiofrequency energy, the AV node can be modified, usually at the slow pathway, with a large-tipped catheter in the same procedure as the electrophysiologic study. The approaches to AV node slow pathway modification are generally anatomical (ie, creating a line or lines of block across the usual site of the slow-pathway entrance) or guided by slow-pathway potentials.[32] Successful deliveries of energy often are associated with a smooth and gradual acceleration of junctional tachycardia.[33] AV conduction must be assessed carefully during energy application to ensure that heart block is not created. Successful ablation usually is associated with a loss of the jump in conduction, fewer or no AV nodal echo beats, and failure to reinduce tachycardia.

With cryothermal energy, the advantage of creating a map for subsequent ablation has been partly obscured by the finding that in some patients, the mapped location does not predict the actual successful spot, with a reported negative predictive value of 66% in some series.[34] Also, transient AV block was noted in other patients, where the map has previously shown to be a safe location. So far, no permanent AV block has been described with cryomapping/ablation; however, the patient numbers are still small. A recent meta-analysis concluded that cryoablation is a safe and effective treatment. Late recurrences were more common with cryoablation; however, avoidance of AV nodal block was noted.[35]

Postcatheterization complications include hemorrhage, pain, nausea and vomiting, rhythm abnormalities, and arterial or venous obstruction from thrombosis or spasm. Although the long-term sequelae of AVNRT ablation are unknown, one study of pediatric patients has described changes in atrial size and electrophysiology 2-5 years following ablation.[36]

Cyroablation has been shown to be more successful with increased individual experience in one study. This showed a decreased recurrence rate from 28% in the first 25 cases to 8.9% in the last 45 cases.[37]

Current electroanatomic mapping systems have led to a significant decrease in fluoroscopy use and thus radiation exposure during electrophysiology studies and ablation.[38] Intracardiac echocardiography has also been used in conjunction with electroanatomic mapping to lower radiation exposure.[39]

Some authors have suggested that cryoablation has a lower recurrence rate when performed at a younger age.[40]

One study showed early transient AV block following cryotherapy in 18% of patients; however, in all patients, there was no evidence of AV nodal dysfunction 24 hours following the procedure.[41]

Previous
 
 
Contributor Information and Disclosures
Author

Glenn T Wetzel, MD, PhD Professor of Pediatrics, University of Tennessee College of Medicine; Director, Pediatric Arrhythmia Service, Le Bonheur Children's Hospital

Glenn T Wetzel, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, Heart Rhythm Society

Disclosure: Nothing to disclose.

Coauthor(s)

Ryan Jones, MD Assistant Professor, Division of Pediatric Cardiology, Department of Pediatrics, University of Tennessee Health Science Center Memphis

Ryan Jones, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Hugh D Allen, MD Professor, Department of Pediatrics, Division of Pediatric Cardiology and Department of Internal Medicine, Ohio State University College of Medicine

Hugh D Allen, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Echocardiography, Society for Pediatric Research, Society of Pediatric Echocardiography, Western Society for Pediatric Research, American College of Cardiology, American Heart Association, American Pediatric Society

Disclosure: Nothing to disclose.

Chief Editor

Stuart Berger, MD Medical Director of The Heart Center, Children's Hospital of Wisconsin; Associate Professor, Department of Pediatrics, Section of Pediatric Cardiology, Medical College of Wisconsin

Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, Society for Cardiovascular Angiography and Interventions

Disclosure: Nothing to disclose.

Additional Contributors

Charles I Berul, MD Professor of Pediatrics and Integrative Systems Biology, George Washington University School of Medicine; Chief, Division of Cardiology, Children's National Medical Center

Charles I Berul, MD is a member of the following medical societies: American Academy of Pediatrics, Heart Rhythm Society, Cardiac Electrophysiology Society, Pediatric and Congenital Electrophysiology Society, American College of Cardiology, American Heart Association, Society for Pediatric Research

Disclosure: Received grant/research funds from Medtronic for consulting.

Acknowledgements

The authors and editors of Medscape Drugs & Diseases gratefully acknowledge the contributions of previous authors Robert Hamilton, MD, and Rejane Dillenburg, MD, to the development and writing of this article.

References
  1. Cohen MI, Wieand TS, Rhodes LA, Vetter VL. Electrophysiologic properties of the atrioventricular node in pediatric patients. J Am Coll Cardiol. 1997 Feb. 29(2):403-7. [Medline].

  2. McCanta AC, Collins KK, Schaffer MS. Incidental dual atrioventricular nodal physiology in children and adolescents: clinical follow-up and implications. Pacing Clin Electrophysiol. 2010 Dec. 33(12):1528-32. [Medline].

  3. Van Hare GF. Developmental aspects of atrioventricular node reentry tachycardia. J Electrocardiol. 2008 Nov-Dec. 41(6):480-2. [Medline].

  4. Nakagawa H, Jackman WM. Catheter ablation of paroxysmal supraventricular tachycardia. Circulation. 2007 Nov 20. 116(21):2465-78. [Medline].

  5. Thapar MK, Gillette PC. Dual atrioventricular nodal pathways: a common electrophysiologic response in children. Circulation. 1979 Dec. 60(6):1369-74. [Medline].

  6. Lee KW, Badhwar N, Scheinman MM. Supraventricular tachycardia--part I. Curr Probl Cardiol. 2008 Sep. 33(9):467-546. [Medline].

  7. Blaufox AD, Warsy I, D'Souza M, Kanter R. Transesophageal electrophysiological evaluation of children with a history of supraventricular tachycardia in infancy. Pediatr Cardiol. 2011 Dec. 32(8):1110-4. [Medline].

  8. Segal OR, Gula LJ, Skanes AC, Krahn AD, Yee R, Klein GJ. Differential ventricular entrainment: a maneuver to differentiate AV node reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm. 2009 Apr. 6(4):493-500. [Medline].

  9. Perez-Rodon J, Bazan V, Bruguera-Cortada J, et al. Entrainment from the para-Hisian region for differentiating atrioventricular node reentrant tachycardia from orthodromic atrioventricular reentrant tachycardia. Europace. 2008 Oct. 10(10):1205-11. [Medline].

  10. Hayes JJ, Sharma PP, Smith PN, Vidaillet HJ. Familial atrioventricular nodal reentry tachycardia. Pacing Clin Electrophysiol. 2004 Jan. 27(1):73-6. [Medline].

  11. Katritsis DG, Camm AJ. Classification and differential diagnosis of atrioventricular nodal re-entrant tachycardia. Europace. 2006 Jan. 8(1):29-36. [Medline].

  12. Ho RT, Frisch DR, Pavri BB, Levi SA, Greenspon AJ. Electrophysiological features differentiating the atypical atrioventricular node-dependent long RP supraventricular tachycardias. Circ Arrhythm Electrophysiol. 2013 Jun. 6(3):597-605. [Medline].

  13. Yamabe H, Tanaka Y, Morihisa K, Uemura T, Enomoto K, Kawano H. Analysis of the anatomical tachycardia circuit in verapamil-sensitive atrial tachycardia originating from the vicinity of the atrioventricular node. Circ Arrhythm Electrophysiol. 2010 Feb. 3(1):54-62. [Medline].

  14. Josephson ME, Wellens HJ. Differential diagnosis of supraventricular tachycardia. Cardiol Clin. 1990 Aug. 8(3):411-42. [Medline].

  15. Mahajan T, Berul CI, Cecchin F, Triedman JK, Alexander ME, Walsh EP. Atrioventricular nodal reentrant tachycardia with 2:1 block in pediatric patients. Heart Rhythm. 2008 Oct. 5(10):1391-5. [Medline].

  16. Goldberger J, Brooks R, Kadish A. Physiology of "atypical" atrioventricular junctional reentrant tachycardia occurring following radiofrequency catheter modification of the atrioventricular node. Pacing Clin Electrophysiol. 1992 Dec. 15(12):2270-82. [Medline].

  17. Okumura Y, Watanabe I, Yamada T, et al. Comparison of coronary sinus morphology in patients with and without atrioventricular nodal reentrant tachycardia by intracardiac echocardiography. J Cardiovasc Electrophysiol. 2004 Mar. 15(3):269-73. [Medline].

  18. Blurton DJ, Dubin AM, Chiesa NA, Van Hare GF, Collins KK. Characterizing dual atrioventricular nodal physiology in pediatric patients with atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol. 2006 Jun. 17(6):638-44. [Medline].

  19. Dobreanu D, Micu S, Toma O, Rudzik R. Intraprocedural predictors of successful ablation of slow pathway for atrioventricular nodal reentrant tachycardia. Rom J Intern Med. 2007. 45(1):35-46. [Medline].

  20. Lee PC, Chen SA, Hwang B. Atrioventricular node anatomy and physiology: implications for ablation of atrioventricular nodal reentrant tachycardia. Curr Opin Cardiol. 2009 Mar. 24(2):105-12. [Medline].

  21. Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. 1999 Jan 19. 99(2):262-70. [Medline].

  22. Etheridge SP. Cryoablation for supraventricular tachycardia in children: is it okay to trade success for decreased risk?. J Cardiovasc Electrophysiol. 2005 Sep. 16(9):967-8. [Medline].

  23. Collins KK, Schaffer MS. Use of cryoablation for treatment of tachyarrhythmias in 2010: survey of current practices of pediatric electrophysiologists. Pacing Clin Electrophysiol. 2011 Mar. 34(3):304-8. [Medline].

  24. Kirsh JA, Gross GJ, O'Connor S, Hamilton RM. Transcatheter cryoablation of tachyarrhythmias in children: initial experience from an international registry. J Am Coll Cardiol. 2005 Jan 4. 45(1):133-6. [Medline].

  25. Avari JN, Jay KS, Rhee EK. Experience and results during transition from radiofrequency ablation to cryoablation for treatment of pediatric atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol. 2008 Apr. 31(4):454-60. [Medline].

  26. Drago F, De Santis A, Grutter G, Silvetti MS. Transvenous cryothermal catheter ablation of re-entry circuit located near the atrioventricular junction in pediatric patients: efficacy, safety, and midterm follow-up. J Am Coll Cardiol. 2005 Apr 5. 45(7):1096-103. [Medline].

  27. Miyazaki A, Blaufox AD, Fairbrother DL, Saul JP. Prolongation of the fast pathway effective refractory period during cryoablation in children: a marker of slow pathway modification. Heart Rhythm. 2005 Nov. 2(11):1179-85. [Medline].

  28. Van Hare GF, Chiesa NA, Campbell RM, et al. Atrioventricular nodal reentrant tachycardia in children: effect of slow pathway ablation on fast pathway function. J Cardiovasc Electrophysiol. 2002 Mar. 13(3):203-9. [Medline].

  29. Chanani NK, Chiesa NA, Dubin AM, Avasarala K, Van Hare GF, Collins KK. Cryoablation for atrioventricular nodal reentrant tachycardia in young patients: predictors of recurrence. Pacing Clin Electrophysiol. 2008 Sep. 31(9):1152-9. [Medline]. [Full Text].

  30. Eckhardt LL, Leal M, Hollis Z, Tanega J, Alberte C. Cryoablation for AVNRT: Importance of Ablation Endpoint Criteria. J Cardiovasc Electrophysiol. 2012 Apr 17. [Medline].

  31. Silka MJ, Kron J, Park JK, et al. Atypical forms of supraventricular tachycardia due to atrioventricular node reentry in children after radiofrequency modification of slow pathway conduction. J Am Coll Cardiol. 1994 May. 23(6):1363-9. [Medline].

  32. Rhodes LA, Wieand TS, Vetter VL. Low temperature and low energy radiofrequency modification of atrioventricular nodal slow pathways in pediatric patients. Pacing Clin Electrophysiol. 1999 Jul. 22(7):1071-8. [Medline].

  33. Epstein MR, Saul JP, Fishberger SB, et al. Spontaneous accelerated junctional rhythm: an unusual but useful observation prior to radiofrequency catheter ablation for atrioventricular node reentrant tachycardia in young patients. Pacing Clin Electrophysiol. 1997 Jun. 20(6):1654-61. [Medline].

  34. Kriebel T, Broistedt C, Kroll M, et al. Efficacy and safety of cryoenergy in the ablation of atrioventricular reentrant tachycardia substrates in children and adolescents. J Cardiovasc Electrophysiol. 2005 Sep. 16(9):960-6. [Medline].

  35. Hanninen M, Yeung-Lai-Wah N, Massel D, Gula LJ, Skanes AC, Yee R, et al. Cryoablation versus RF ablation for AVNRT: A meta-analysis and systematic review. J Cardiovasuclar Electrophysiology. Dec 2013. 24:1354-60. [Medline].

  36. Sileikiene R, Vaskelyte J, Mizariene V, Nedzelskiene I, Verseckaite R, Jurkevicius R, et al. Heart rate variability and atria function in children at late follow-up evaluation after atrioventricular node slow-pathway radiofrequency ablation. Pediatr Cardiol. 2011 Aug. 32(6):792-800. [Medline]. [Full Text].

  37. Cokkinakis C, Avramidis D, Alexopoulos C, Kirvassilis G, Papagiannis J. Cryoablation of atrioventricular nodal reentrant tachycardia in children and adolescents: improved long-term outcomes with increasing experience. Hellenic J Cardiol. 2013 May-Jun. 54(3):186-91. [Medline].

  38. Scaglione M, Ebrille E, Caponi D, Blandion A DI Donna P, Siboldi A, Bertero G, et al. Single center experience of fluoroless AVNRT ablation guided by electroanatomic reconstruction in children and adolescents. Pacing Clinical Electrophysiology. Dec 2013. 36:1460-7. [Medline].

  39. Mah DY, Miyake CY, Sherwin ED, Walsh A, Anderson MJ, Western K, et al. The use of an integrated electroanatomic mapping system and intracardiac echocardiography to reduce radiation exposure in children and young adults undergoing ablation of supraventricular tachycardia. Europace. Feb 2014. 16:277-83. [Medline].

  40. Drago F, Placidi S, Righi D, DI Mambro C, Russo MS< Silvetti MS, Palmieri R, et al. Cryobaltaion of AVNRT in Children and Adolescents: Early Intervention Leads to a Better Outcome. J Cardiovascular Electrophysiology. April 2014. 25:398-403. [Medline].

  41. Kiplapinar N, Ergul Y, Akdeniz C, Saygi M, Ozyilmaz I, Gul EE, et al. Assessment of Atrioventricular Conduction Following Cryoablation of Atrioventricular Nodal Reentrant Tachycardia in Children. Pacing Clinical Electrophysiology. Jan 2014. e-pub. [Medline].

  42. Dixon J, Foster K, Wyllie J, Wren C. Guidelines and adenosine dosing in supraventricular tachycardia. Arch Dis Child. 2005 Nov. 90(11):1190-1. [Medline].

  43. Ratnasamy C, Rossique-Gonzalez M, Young ML. Pharmacological therapy in children with atrioventricular reentry: which drug?. Curr Pharm Des. 2008. 14(8):753-61. [Medline].

  44. Shah A, Moon-Grady A, Bhogal N, Collins KK, Tacy T, Brook M, et al. Effectiveness of Sotalol as First-Line Therapy for Fetal Supraventricular Tachyarrhythmias. Am J Cardiol. 2012 Mar 21. [Medline].

 
Previous
Next
 
The patient's heart rate is approximately 146 beats per minute with a normal axis. Note the pseudo S waves in leads II, III, and aVF. Also note the pseudo R' waves in V1 and aVR. These deflections represent retrograde atrial activation.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.